Childhood peanut allergy rates fall sharply after medical advice changed
A new study links the 43% decline in young children with peanut allergies to a shift toward early introduction of the food in infancy.
By Priya Marino ·
Peanut allergy rates among children under age 3 have dropped by approximately 43% over the past ten years, according to a study released in October 2025. The data indicates a substantial reversal in a condition that previously affected a much larger portion of the pediatric population.
Dr. David Hill, the lead author of the research, attributes the decline primarily to a change in medical guidance regarding infant feeding. For years, doctors advised parents to delay introducing peanuts to babies to prevent reactions. Hill believes this previous advice was counterproductive. He states that early introduction of peanut products between four and six months of age has likely prevented the condition in tens of thousands of children.
Kristie Herring, a mother from the region, experienced the severity of peanut allergies firsthand with her son, Parker. Herring described the diagnosis as a total surprise, noting that her family had no known history of the condition. Parker now undergoes oral immunotherapy, a treatment process that involves gradually increasing the dose of peanut protein. This regimen has allowed him to safely consume peanut butter again, a change that transformed daily life for the family.
The American Academy of Pediatrics now advises parents to introduce peanut products to all infants who have no prior history of allergic reactions, provided they are already eating other solid foods. Pediatricians recommend starting with small amounts and serving peanut foods at least twice a week throughout the first year. They emphasize that whole peanuts should never be given to infants due to the risk of choking. Parents are also advised to consult allergists for children who have already developed the condition.
Experts caution that early introduction is not a guaranteed cure for every child. Food allergy remains a complex medical issue with multiple contributing factors. Oral immunotherapy, while effective for many, carries its own set of risks and requires careful monitoring by specialists. The new guidelines aim to reduce the overall incidence of new cases rather than treat those already diagnosed.
